首页 | 本学科首页   官方微博 | 高级检索  
     


Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis
Authors:Srinevas K. Reddy MD  Timothy M. Pawlik MD   MPH  Daria Zorzi MD  Ana L. Gleisner MD  Dario Ribero MD  Lia Assumpcao MD  Andrew S. Barbas BS  Eddie K. Abdalla MD  Michael A. Choti MD  Jean-Nicolas Vauthey MD  Kirk A. Ludwig MD  Christopher R. Mantyh MD  Michael A. Morse MD  Bryan M. Clary MD
Affiliation:(1) Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA;(2) Departments of Medicine, Duke University Medical Center, Durham, NC 27710, USA;(3) Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA;(4) Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Abstract:Background The safety of simultaneous resections of colorectal cancer and synchronous liver metastases (SCRLM) is not established. This multi-institutional retrospective study compared postoperative outcomes after simultaneous and staged colorectal and hepatic resections. Methods Clinicopathologic data, treatments, and postoperative outcomes from patients who underwent simultaneous or staged colorectal and hepatic resections at three hepatobiliary centers from 1985–2006 were reviewed. Results 610 patients underwent simultaneous (n = 135) or staged (n = 475) resections of colorectal cancer and SCRLM. Seventy staged patients underwent colorectal and hepatic resections at the same institution. Simultaneous patients had fewer (median 1 versus 2) and smaller (median 2.5 versus 3.5 cm) metastases and less often underwent major (≥ three segments) hepatectomy (26.7% versus 61.3%, p < 0.05). Combined hospital stay was lower after simultaneous resections (median 8.5 versus 14 days, p < 0.0001). Mortality (1.0% versus 0.5%) and severe morbidity (14.1% versus 12.5%) were similar after simultaneous colorectal resection and minor hepatectomy compared with isolated minor hepatectomy (both p > 0.05). For major hepatectomy, simultaneous colorectal resection increased mortality (8.3% versus 1.4%, p < 0.05) and severe morbidity (36.1% versus 15.1%, p < 0.05). Combined severe morbidity after staged resections was lower compared to simultaneous resections (36.1% versus 17.6%, p = 0.05) for major hepatectomy but similar for minor hepatectomy (14.1% versus 10.5%, p > 0.05). Major hepatectomy independently predicted severe morbidity after simultaneous resections [hazard ratio (HR) = 3.4, p = 0.008]. Conclusions Simultaneous colorectal and minor hepatic resections are safe and should be performed for most patients with SCRLM. Due to increased risk of severe morbidity, caution should be exercised before performing simultaneous colorectal and major hepatic resections.
Keywords:Simultaneous  Colorectal cancer  Hepatic metastases  Hepatectomy  Chemotherapy  Resection
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号